Trial Outcomes & Findings for Interbody Fusion Devices in the Treatment of Cervicobrachial Syndrome (NCT NCT01511445)
NCT ID: NCT01511445
Last Updated: 2017-05-08
Results Overview
The change in the Neck Disability Index compared to the pre-op value for each group will be compared. Neck disability index is a unitless measure from zero (no disability) to 100 (absolute disability). Change is calculated as the pre-op value minus the 24 month value. A negative difference indicates that the patient is more disabled at 24 months.
COMPLETED
NA
100 participants
24 months post-op
2017-05-08
Participant Flow
The study was designed as double-blind randomized trial. The design called for randomizing 100 patients.
Four additional patients were randomized when four patients were excluded for protocol violations prior to the primary endpoint. A surgeon who had not been trained as an investigator operated on these four patients, making numerous protocol violations in implant technique. These patients were randomized and had pre-op data in the study.
Participant milestones
| Measure |
ACDF With Valeo CSC Ceramic Cage
ACDF with the Valeo CSC cage, a silicon nitride ceramic interbody cage. The center area of the cage is filled with porous silicon nitride. No autologous bone is used; the cage is soaked in patient blood.
Anterior cervical discectomy and fusion (ACDF) with a Valeo CSC Cage: Anterior cervical discectomy and fusion with a Valeo ceramic cage interbody spacer.
|
ACDF With PEEK Interbody Cage
Anterior cervical discectomy and fusion (ACDF) with an interbody spacer made from polyetheretherketone (PEEK) plastic. The open space in the center of the cage is to be filled with local autologous bone harvested during the decompression phase of the procedure.
Anterior cervical discectomy and fusion (ACDF) with PEEK Cage: Anterior cervical discectomy and fusion with the use of a PEEK plastic interbody spacer
|
|---|---|---|
|
Overall Study
STARTED
|
53
|
51
|
|
Overall Study
Surgeries Completed
|
53
|
51
|
|
Overall Study
Primary Completion October, 2014
|
48
|
47
|
|
Overall Study
Follow-up Completion
|
48
|
47
|
|
Overall Study
COMPLETED
|
48
|
47
|
|
Overall Study
NOT COMPLETED
|
5
|
4
|
Reasons for withdrawal
| Measure |
ACDF With Valeo CSC Ceramic Cage
ACDF with the Valeo CSC cage, a silicon nitride ceramic interbody cage. The center area of the cage is filled with porous silicon nitride. No autologous bone is used; the cage is soaked in patient blood.
Anterior cervical discectomy and fusion (ACDF) with a Valeo CSC Cage: Anterior cervical discectomy and fusion with a Valeo ceramic cage interbody spacer.
|
ACDF With PEEK Interbody Cage
Anterior cervical discectomy and fusion (ACDF) with an interbody spacer made from polyetheretherketone (PEEK) plastic. The open space in the center of the cage is to be filled with local autologous bone harvested during the decompression phase of the procedure.
Anterior cervical discectomy and fusion (ACDF) with PEEK Cage: Anterior cervical discectomy and fusion with the use of a PEEK plastic interbody spacer
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
3
|
1
|
|
Overall Study
Protocol Violation
|
1
|
0
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
ACDF With Valeo CSC Ceramic Cage
n=53 Participants
ACDF with the Valeo CSC cage, a silicon nitride ceramic interbody cage.
|
ACDF With PEEK Interbody Cage
n=51 Participants
Anterior cervical discectomy and fusion (ACDF) with an interbody spacer made from polyetheretherketone (PEEK) plastic.
|
Total
n=104 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
53.3 years
STANDARD_DEVIATION 9.3 • n=53 Participants
|
49.6 years
STANDARD_DEVIATION 9.5 • n=51 Participants
|
51.3 years
STANDARD_DEVIATION 9.5 • n=104 Participants
|
|
Sex: Female, Male
Female
|
27 Participants
n=53 Participants
|
25 Participants
n=51 Participants
|
52 Participants
n=104 Participants
|
|
Sex: Female, Male
Male
|
26 Participants
n=53 Participants
|
26 Participants
n=51 Participants
|
52 Participants
n=104 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
Netherlands
|
53 participants
n=53 Participants
|
51 participants
n=51 Participants
|
104 participants
n=104 Participants
|
|
Use of nicotine products
|
23 Participants
n=53 Participants
|
20 Participants
n=51 Participants
|
43 Participants
n=104 Participants
|
|
Symptomatic (operated) spinal level
C3-C4
|
1 Participants
n=53 Participants
|
1 Participants
n=51 Participants
|
2 Participants
n=104 Participants
|
|
Symptomatic (operated) spinal level
C4-C5
|
0 Participants
n=53 Participants
|
6 Participants
n=51 Participants
|
6 Participants
n=104 Participants
|
|
Symptomatic (operated) spinal level
C5-C6
|
30 Participants
n=53 Participants
|
30 Participants
n=51 Participants
|
60 Participants
n=104 Participants
|
|
Symptomatic (operated) spinal level
C6-C7
|
20 Participants
n=53 Participants
|
12 Participants
n=51 Participants
|
32 Participants
n=104 Participants
|
|
Symptomatic (operated) spinal level
C7-T1
|
2 Participants
n=53 Participants
|
2 Participants
n=51 Participants
|
4 Participants
n=104 Participants
|
PRIMARY outcome
Timeframe: 24 months post-opPopulation: Patients who had data from 24 month follow-up visit
The change in the Neck Disability Index compared to the pre-op value for each group will be compared. Neck disability index is a unitless measure from zero (no disability) to 100 (absolute disability). Change is calculated as the pre-op value minus the 24 month value. A negative difference indicates that the patient is more disabled at 24 months.
Outcome measures
| Measure |
ACDF With Valeo CSC Ceramic Cage
n=47 Participants
ACDF with the Valeo CSC cage, a silicon nitride ceramic interbody cage.
|
ACDF With PEEK Interbody Cage
n=44 Participants
Anterior cervical discectomy and fusion (ACDF) with an interbody spacer made from polyetheretherketone (PEEK) plastic.
|
|---|---|---|
|
Neck Disability Index
|
17.9 units on a scale from 0 to 100
Standard Deviation 14.9
|
16.7 units on a scale from 0 to 100
Standard Deviation 16.1
|
SECONDARY outcome
Timeframe: 3 mo., 6mo., 12 mo., 24 monthsPopulation: Patients with 24 month films
Dynamic flexion-extension plane film x-rays will be used to assess fusion at all four follow-up periods. The criteria for fusion are rotation motion less than or equal to four degrees and translation less than 1.25 mm. The final fusion judgement will be fusion status at 24 months or the last time point with flexion-extension data available.
Outcome measures
| Measure |
ACDF With Valeo CSC Ceramic Cage
n=43 Participants
ACDF with the Valeo CSC cage, a silicon nitride ceramic interbody cage.
|
ACDF With PEEK Interbody Cage
n=41 Participants
Anterior cervical discectomy and fusion (ACDF) with an interbody spacer made from polyetheretherketone (PEEK) plastic.
|
|---|---|---|
|
Fusion Status
|
40 Participants
|
37 Participants
|
Adverse Events
ACDF With Valeo CSC Ceramic Cage
ACDF With PEEK Interbody Cage
Serious adverse events
| Measure |
ACDF With Valeo CSC Ceramic Cage
n=53 participants at risk
ACDF with the Valeo CSC cage, a silicon nitride ceramic interbody cage.
|
ACDF With PEEK Interbody Cage
n=51 participants at risk
Anterior cervical discectomy and fusion (ACDF) with an interbody spacer made from polyetheretherketone (PEEK) plastic.
|
|---|---|---|
|
Musculoskeletal and connective tissue disorders
Replacement of implant due to subsidence
|
1.9%
1/53 • Number of events 1
Investigators completed adverse event questionnaires and patients were surveyed for adverse events at each interaction with the investigational team
|
2.0%
1/51 • Number of events 1
Investigators completed adverse event questionnaires and patients were surveyed for adverse events at each interaction with the investigational team
|
|
Infections and infestations
Debridement of abscess
|
1.9%
1/53 • Number of events 1
Investigators completed adverse event questionnaires and patients were surveyed for adverse events at each interaction with the investigational team
|
0.00%
0/51
Investigators completed adverse event questionnaires and patients were surveyed for adverse events at each interaction with the investigational team
|
Other adverse events
| Measure |
ACDF With Valeo CSC Ceramic Cage
n=53 participants at risk
ACDF with the Valeo CSC cage, a silicon nitride ceramic interbody cage.
|
ACDF With PEEK Interbody Cage
n=51 participants at risk
Anterior cervical discectomy and fusion (ACDF) with an interbody spacer made from polyetheretherketone (PEEK) plastic.
|
|---|---|---|
|
Injury, poisoning and procedural complications
Dysphasia
|
17.0%
9/53 • Number of events 9
Investigators completed adverse event questionnaires and patients were surveyed for adverse events at each interaction with the investigational team
|
15.7%
8/51 • Number of events 8
Investigators completed adverse event questionnaires and patients were surveyed for adverse events at each interaction with the investigational team
|
|
Musculoskeletal and connective tissue disorders
Surgery at additional spinal level
|
11.3%
6/53 • Number of events 6
Investigators completed adverse event questionnaires and patients were surveyed for adverse events at each interaction with the investigational team
|
5.9%
3/51 • Number of events 3
Investigators completed adverse event questionnaires and patients were surveyed for adverse events at each interaction with the investigational team
|
|
Immune system disorders
Removal for restenosis
|
1.9%
1/53 • Number of events 1
Investigators completed adverse event questionnaires and patients were surveyed for adverse events at each interaction with the investigational team
|
0.00%
0/51
Investigators completed adverse event questionnaires and patients were surveyed for adverse events at each interaction with the investigational team
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place